Synaptic Plasticity-Intrinsic Excitability and Antidepressant Discovery

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• Major depressive disorder (MDD) is a leading cause of disability with limited relief from traditional monoamine-based antidepressants.
• Rapid-acting antidepressants show promise by linking symptom improvement to glutamatergic plasticity, but durable effects require circuit stabilization.
• Understanding the mechanisms of circuit stabilization is crucial for developing more effective and lasting antidepressant therapies.

Purpose of the Study:

• To synthesize evidence on the roles of synaptic plasticity and intrinsic excitability in antidepressant efficacy.
• To propose an integrated framework, the Induction-Consolidation-Maintenance (ICM) model, for guiding future antidepressant discovery.
• To link specific phases of neural circuit modulation to therapeutic windows and relapse prevention.

Main Methods:

• Review of existing scientific literature on synaptic plasticity and intrinsic excitability in antidepressant action.
• Analysis of molecular and cellular mechanisms involved in the induction and consolidation of synaptic changes.
• Examination of the role of ion channels in regulating neuronal excitability and network stability.

Main Results:

• Antidepressant efficacy involves coordinated synaptic plasticity (induction via NMDARs/AMPARs, consolidation via TrkB/eEF2K/SV2A) and intrinsic excitability (Kv7, HCN, GIRK channels).
• These processes transform transient potentiation into persistent network changes, crucial for sustained therapeutic benefit.
• The ICM framework integrates these phases, suggesting distinct therapeutic windows and biomarker applications.

Conclusions:

• A phase-specific model (ICM) integrating synaptic plasticity and intrinsic excitability provides a roadmap for novel antidepressant development.
• This framework highlights the importance of circuit stabilization for durable antidepressant effects.
• Biomarkers like SV2A PET, EEG, and fMRI are discussed as potential tools, though validation for treatment guidance is pending.